| Literature DB >> 36130486 |
Xiyuan Zhang1, Hannah E Lou1, Vishaka Gopalan2, Zhihui Liu1, Hilda M Jafarah1, Haiyan Lei1, Paige Jones1, Carly M Sayers1, Marielle E Yohe1, Prashant Chittiboina3, Brigitte C Widemann1, Carol J Thiele1, Michael C Kelly4, Sridhar Hannenhalli2, Jack F Shern5.
Abstract
Loss-of-function mutations in the polycomb repressive complex 2 (PRC2) occur frequently in malignant peripheral nerve sheath tumor, an aggressive sarcoma that arises from NF1-deficient Schwann cells. To define the oncogenic mechanisms underlying PRC2 loss, we use engineered cells that dynamically reassemble a competent PRC2 coupled with single-cell sequencing from clinical samples. We discover a two-pronged oncogenic process: first, PRC2 loss leads to remodeling of the bivalent chromatin and enhancer landscape, causing the upregulation of developmentally regulated transcription factors that enforce a transcriptional circuit serving as the cell's core vulnerability. Second, PRC2 loss reduces type I interferon signaling and antigen presentation as downstream consequences of hyperactivated Ras and its cross talk with STAT/IRF transcription factors. Mapping of the transcriptional program of these PRC2-deficient tumor cells onto a constructed developmental trajectory of normal Schwann cells reveals that changes induced by PRC2 loss enforce a cellular profile characteristic of a primitive mesenchymal neural crest stem cell. Published by Elsevier Inc.Entities:
Keywords: CP: Cancer; FOXC1; HOXB8; NF1; PRC2; bivalent gene; neural crest stem cell; neurofibromatosis type 1; polycomb repressive complex 2; single-cell sequencing; transcription factor
Mesh:
Substances:
Year: 2022 PMID: 36130486 PMCID: PMC9585487 DOI: 10.1016/j.celrep.2022.111363
Source DB: PubMed Journal: Cell Rep Impact factor: 9.995